Metalloradiopharmaceuticals are used in more than 80% of the diagnostic procedures
performed in nuclear medicine each year and represent an increasing fraction of the …

Metalâ•’Based Radiopharmaceuticals Page 1 9 Metal-Based Radiopharmaceuticals Roger
Alberto 9.1 Introduction The non-invasive diagnosis and therapy of socially relevant diseases …

Nuclear medicine is composed of two complementary areas, imaging and therapy. Positron
emission tomography (PET) and single-photon imaging, including single-photon emission …

Radiopharmaceuticals, drugs containing a radionu-clide, are used routinely in nuclear
medicine depart-ments for the diagnosis of disease and are under investigation for use in …

This volume explores the potential of technetium radiopharmaceuticals in clinical nuclear
medicine. The authors examine the capabilities of synthetic inorganic chemists to synthesize …

The clinical use of radioactivity centered upon diagnosis and therapy constitutes one of the
greatest advances in non-invasive medicine. This medical field is called nuclear medicine …

Although molecular imaging agents have to be synthesized ultimately from aqueous
solutions, organometallic complexes are becoming more and more important as flexible yet …

Radiometals are, and will continue to be, very important to diagnostic and therapeutic
nuclear medicine applications as they predominantly possess the most suitable nuclear …

Bioinorganic activity of technetium radiopharmaceuticals Page 1 Bioinorganic Activity of
Technetium Radiopharmaceuticals Thomas C. Pinkerton, Carla P. Desilets, Daniel J. Hoch …

Technetium radiopharmaceuticals as diagnostic organ imaging agents Page 1 Peter Valk,
James McRae, and Alan J. Bearden University of California Berkeley, 94720 Peter Hambright …